Try it
Microbiology · Immunology: HLA and drug hypersensitivity
Sample itemBefore prescribing abacavir to a patient with HIV, which test is advised to prevent a potentially fatal systemic hypersensitivity reaction?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. HLA-B*57:01 genotyping
Abacavir hypersensitivity, with fever, rash, gastrointestinal and respiratory symptoms, is strongly associated with HLA-B*57:01, which presents the drug-altered peptide repertoire to T cells. Screening before therapy and avoiding the drug in carriers essentially prevents the reaction.
Option by option
A. HLA-B*57:01 genotyping (correct)
Correct. Carriers of HLA-B*57:01 should not receive abacavir.
B. HLA-B*27 typing
HLA-B27 is associated with ankylosing spondylitis and reactive arthritis.
C. HLA-DR3 typing
HLA-DR3 is associated with conditions such as Graves disease and type 1 diabetes.
D. HLA-DQ2 typing
HLA-DQ2 is associated with coeliac disease.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Microbiology questions
- BacteriologyA patient has profuse painless watery 'rice-water' stools and rapid dehydration. The cau…
- Culture mediaThayer–Martin medium is used selectively to isolate which organism?
- Immunology and serologyWhich of the following is a non-treponemal test for syphilis?
- BacteriologyAlbert's stain is used to demonstrate which of the following?